Predicted to enable glycosaminoglycan binding activity. Predicted to act upstream of or within peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan. Predicted to be located in endoplasmic reticulum and interstitial matrix. Orthologous to human MAMDC2 (MAM domain containing 2). [provided by Alliance of Genome Resources, Apr 2022]